Johnson & Johnson (JNJ)

JNJ (NYSE:Drugs) EQUITY
$101.62
neg -0.11
-0.11%
Today's Range: 99.98 - 102.02 | JNJ Avg Daily Volume: 8,893,500
Last Update: 02/11/16 - 3:59 PM EST
Volume: 12,400,902
YTD Performance: -0.96%
Open: $100.46
Previous Close: $101.73
52 Week Range: $81.79 - $105.49
Oustanding Shares: 2,766,943,629
Market Cap: 282,145,241,849
6-Month Chart
TheStreet Ratings Grade for JNJ
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 7 7 6
Moderate Buy 1 1 1 2
Hold 6 6 6 7
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.93 1.93 1.93 2.07
Latest Dividend: 0.75
Latest Dividend Yield: 2.94%
Dividend Ex-Date: 02/19/16
Price Earnings Ratio: 15.08
Price Earnings Comparisons:
JNJ Sector Avg. S&P 500
15.08 18.60 27.19
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.28% 1.38% 34.78%
GROWTH 12 Mo 3 Yr CAGR
Revenue 4.20 0.04 0.01
Net Income -5.60 0.47 0.13
EPS -3.90 0.41 0.12
Earnings for JNJ:
EBITDA 18.29B
Revenue 70.07B
Average Earnings Estimates
Qtr (03/16) Qtr (06/16) FY (12/16) FY (12/17)
Average Estimate $1.64 $1.65 $6.51 $6.84
Number of Analysts 10 9 10 12
High Estimate $1.72 $1.68 $6.58 $7.12
Low Estimate $1.56 $1.62 $6.49 $6.50
Prior Year $1.56 $1.71 $6.20 $6.51
Growth Rate (Year over Year) 5.26% -3.44% 5.00% 5.02%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Feb 11, 2016 | 3:44 PM EST

Finding stocks that are caught in the market vortex but shouldn't be going down is the key to coming out a winner.

By

Tony Owusu

 | Feb 10, 2016 | 12:55 PM EST

Janet Yellen's Congressional hearing and volatile oil prices are not enough to hurt the stock market. 

By

Tony Owusu

 | Feb 10, 2016 | 9:03 AM EST

U.S. futures look to build off of Tuesday's afternoon rally.

By

Antonia Oprita

 | Feb 8, 2016 | 8:00 AM EST

As we're talking ourselves into a recession, pressures on executives increase.

By

Skip Raschke

 | Feb 1, 2016 | 8:30 AM EST

An out-of-the-money, bullishly biased vertical call spread.

By

Jim Cramer

 | Jan 29, 2016 | 11:31 AM EST

These major names still have higher to climb.

By

Jim Cramer

 | Jan 27, 2016 | 5:40 AM EST

Janet Yellen and her colleagues should listen to companies' conference calls.

By

James "Rev Shark" DePorre

 | Jan 26, 2016 | 4:22 PM EST

But this was a good day to be a contrarian.

By

Ben Cross

 | Jan 26, 2016 | 4:04 PM EST

Despite another drop in Chinese equities, copper and zinc have rallied more than 2%.

By

Jim Cramer

 | Jan 26, 2016 | 3:36 PM EST

Along came quality earnings from a few solid companies and the narrative changed.

Reasons to trail down stops on shorts in the indices and also to consider longs if the buy...

JPMorgan Chase's CEO Jamie Dimon buys 500K shares of the company - CNBC, citing DJ

Bunge (BG) reported so-so earnings today while warning the new year is starting off dully....
I mentioned in my earlier comment to Doug Kass that I thought the algos would trigger the ...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.